19 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28252961	13	Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.	Goethe-University Frankfurt
27908761	55	Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.	Eli Lilly
26985325	62	Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.	Shanghai Institute of Materia Medica
26421921	43	Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists.	Glenmark Research Centre
26200813	90	Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.	Setsunan University
25800431	30	Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid.	Ono Pharmaceutical
25408836	44	Discovery of Highly Potent Dual CysLT1 and CysLT2 Antagonist.	Ono Pharmaceutical
20875743	90	Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity rela	Pfizer
20621485	81	Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists.	Zhejiang University
8709092	21	Modulators of leukotriene biosynthesis and receptor activation.	Abbott Laboratories
8496700	16	The Role of Receptor Binding in Drug Discovery	TBA
	21	Discovery of L-740,515, a potent thienopyridine cysLT1 receptor (LTD4 receptor) antagonist	TBA
9871597	65	A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.	Merck Frosst Center For Therapeutic Research
3035179	5	High-affinity leukotriene receptor antagonists. Synthesis and pharmacological characterization of 2-hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl] propanoic acid.	TBA
2170650	4	Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist.	Merck Frosst Centre For Therapeutic Research
2170649	37	The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency.	Rorer Central Research
1372359	3	Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents.	Warner-Lambert